3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Laryngeal Neoplasms
3
Head and Neck Neoplasms
3
Uterine Cervical Neoplasms
2
Stomatitis
2
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Hematologic Neoplasms
2
Dyspareunia
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vomiting
1
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Squamous Intraepithelial Lesions
1
Soft Tissue Neoplasms
1
Radiodermatitis
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Pain
1
Ovarian Neoplasms
1
Neoplasms
1
Mucositis
1
HIV Infections
1
Endometrial Neoplasms
1
Eczema
1
Dermatitis
1
Cicatrix
1
Cancer Pain
1
Interventions
Fluorouracil
12
Radiotherapy
8
Cisplatin
8
pembrolizumab
4
Papillomavirus Vaccines
4
Mitomycin
4
Irinotecan
4
Cyclophosphamide
4
Cetuximab
4
Light Coagulation
3
Interleukin-12 Subunit p35
3
Capecitabine
3
fludarabine phosphate
2
fludarabine
2
atezolizumab
2
aldesleukin
2
Watchful Waiting
2
Vaccines
2
Trastuzumab
2
Surveys and Questionnaires
2
Radiation
2
Quality of Life
2
Paclitaxel
2
Oxaliplatin
2
Erlotinib Hydrochloride
2
Early Intervention, Educational
2
Carboplatin
2
Biopsy
2
toripalimab
1
tipifarnib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Anus Neoplasms
×
Laser Therapy
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts